Similarly, HCC-TCM treatment upregulated the expression of Wnt2b, CTNNB1 (β-catenin) and Axin-2, an universal target molecule of Wnt/beta-catenin signal in PBMC-M (Supplementary Fig. 2C-E). Here, CTNNB1 is linked to hepatocellular carcinoma.